Jurriaan Tuynman

Dr. Jurriaan Tuynman

orcid

Research Focus & Metrics

Academic Career Length

65Years (1962-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2010 in Nature Cell Biology
Verified
Journal Article
Closed access
LVLouis Vermeulen
Louis Vermeulen
FMFelipe De Sousa E Melo
Felipe De Sousa E Melo
MHMaartje van der Heijden
Maartje van der Heijden
KCKate Cameron
Kate Cameron
JJJoan H. de Jong
Joan H. de Jong
JMJan Paul Medema
Jan Paul Medema

14 April 2013 in Nature Medicine
Verified
Journal Article
Closed access
FMFelipe De Sousa E Melo
Felipe De Sousa E Melo
XWXin Wang
Xin Wang
MJMarnix Jansen
Marnix Jansen
EFEvelyn Fessler
Evelyn Fessler
ATAnne Trinh
Anne Trinh
LVLouis Vermeulen
Louis Vermeulen

4 November 2015 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
CDCharlotte L. Deijen
Charlotte L. Deijen
SVSimone Velthuis
Simone Velthuis
ATAlice Tsai
Alice Tsai
SMStella Mavroveli
Stella Mavroveli
EKElly S. M. de Lange-De Klerk
Elly S. M. de Lange-De Klerk
HBH. Jaap Bonjer
H. Jaap Bonjer
Introduction Total mesorectal excision (TME) is an essential component of surgical management of rectal cancer. Both open and laparoscopic TME have been proven to be oncologically safe. However, it remains a challenge to achieve complete TME with clear circumferential resections margin (CRM) with the conventional transabdominal approach, particularly in mid and low rectal tumours. Transanal TME (TaTME) was developed to improve oncological and functional outcomes of patients with mid and low rectal cancer. Methods An international, multicentre, superiority, randomised trial was designed to compare TaTME and conventional laparoscopic TME as the surgical treatment of mid and low rectal carcinomas. The primary endpoint is involved CRM. Secondary endpoints include completeness of mesorectum, residual mesorectum, morbidity and mortality, local recurrence, disease-free and overall survival, percentage of sphincter-saving procedures, functional outcome and quality of life. A Quality Assurance Protocol including centralised MRI review, histopathology re-evaluation, standardisation of surgical techniques, and monitoring and assessment of surgical quality will be conducted. Discussion The difference in involvement of CRM between the two treatment strategies is thought to be in favour of the TaTME. TaTME is therefore expected to be superior to laparoscopic TME in terms of oncological outcomes in case of mid and low rectal carcinomas.

1 November 2011 in Cell Stem Cell
Verified
Journal Article
Closed access
FMFelipe de Sousa E Melo
Felipe de Sousa E Melo
SCSelcuk Colak
Selcuk Colak
JBJoyce Buikhuisen
Joyce Buikhuisen
JKJan Koster
Jan Koster
KCKate Cameron
Kate Cameron
JMJan Paul Medema
Jan Paul Medema

1 August 2013 in Cancer Cell
Verified
Journal Article
Open access
MMMassimo Masiero
Massimo Masiero
FSFilipa Costa Simões
Filipa Costa Simões
HHHee Dong Han
Hee Dong Han
CSCameron Snell
Cameron Snell
TPTessa Peterkin
Tessa Peterkin
FBFrancesca Buffa
Francesca Buffa
Limited clinical benefits derived from anti-VEGF therapy have driven the identification of new targets involved in tumor angiogenesis. Here, we report an integrative meta-analysis to define the transcriptional program underlying angiogenesis in human cancer. This approach identified ELTD1, an orphan G-protein-coupled receptor whose expression is induced by VEGF/bFGF and repressed by DLL4 signaling. Extensive analysis of multiple cancer types demonstrates significant upregulation of ELTD1 in tumor-associated endothelial cells, with a higher expression correlating with favorable prognosis. Importantly, ELTD1 silencing impairs endothelial sprouting and vessel formation in vitro and in vivo, drastically reducing tumor growth and greatly improving survival. Collectively, these results provide insight into the regulation of tumor angiogenesis and highlight ELTD1 as key player in blood vessel formation.

1 October 2019 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
CKCharlotte E L Klaver
Charlotte E L Klaver
DWDaniel D Wisselink
Daniel D Wisselink
CPCornelis J A Punt
Cornelis J A Punt
PSPetur Snaebjornsson
Petur Snaebjornsson
Johannes Hans CrezeeJohannes Hans Crezee
Johannes Hans Crezee
MZMandy Zournas
Mandy Zournas